The current standard of care (SoC) for monitoring chronic kidney disease (CKD) relies primarily on serial measurement of the estimated glomerular filtration rate (eGFR) and urinary albumin–creatinine ratio (uACR). This evidence concerns the gene ALB and chronic kidney disease.